Bolangir Institute Of Medical Science Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 15-11-2024
- Paid Up Capital ₹ 1.00 M
as on 15-11-2024
- Company Age 2 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.00 Cr
as on 15-11-2024
About Bolangir Institute Of Medical Science
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹8.00 Cr.
Hrudananda Biswal, Deepak Tiwari, Gousiya, and Four other members serve as directors at the Company.
- CIN/LLPIN
U85100OR2022PLC039309
- Company No.
039309
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
31 Mar 2022
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Balangir, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bolangir Institute Of Medical Science?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prasanta Swain  | Director | 31-Mar-2022 | Current |
| Aswini Pujahari | Director | 25-Jan-2024 | Current |
| Ashish Sahu | Director | 31-Mar-2022 | Current |
| Hrudananda Biswal | Director | 31-Mar-2022 | Current |
| Deepak Tiwari | Director | 31-Mar-2022 | Current |
| Gousiya | Director | 31-Mar-2022 | Current |
Financial Performance of Bolangir Institute Of Medical Science.
Bolangir Institute Of Medical Science Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bolangir Institute Of Medical Science?
In 2023, Bolangir Institute Of Medical Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bishwaneedam Infrastructure Private LimitedActive 2 years 7 monthsDeepak Tiwari, Jibeswar Behera and 1 more are mutual person
- Srk Automobile And Marketing Private LimitedActive 15 years 21 days
Jibeswar Behera is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 15 Mar 2024 | ₹8.00 Cr | Open |
How Many Employees Work at Bolangir Institute Of Medical Science?
Bolangir Institute Of Medical Science has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bolangir Institute Of Medical Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bolangir Institute Of Medical Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
